Credit Suisse’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-55,652
| Closed | -$1.05M | – | 3674 |
|
|
2019
Q3 | $1.05M | Sell |
55,652
-102,616
| -65% | -$1.94M | ﹤0.01% | 2365 |
|
|
2019
Q2 | $1.86M | Buy |
158,268
+114,851
| +265% | +$1.35M | ﹤0.01% | 1975 |
|
|
2019
Q1 | $593K | Sell |
43,417
-8,390
| -16% | -$115K | ﹤0.01% | 2682 |
|
|
2018
Q4 | $531K | Sell |
51,807
-271,163
| -84% | -$2.78M | ﹤0.01% | 2703 |
|
|
2018
Q3 | $5.38M | Buy |
322,970
+183,855
| +132% | +$3.06M | ﹤0.01% | 1353 |
|
|
2018
Q2 | $2.2M | Sell |
139,115
-71,262
| -34% | -$1.13M | ﹤0.01% | 1990 |
|
|
2018
Q1 | $2.67M | Buy |
210,377
+154,169
| +274% | +$1.96M | ﹤0.01% | 1858 |
|
|
2017
Q4 | $643K | Sell |
56,208
-33,303
| -37% | -$381K | ﹤0.01% | 2812 |
|
|
2017
Q3 | $1.1M | Sell |
89,511
-43,013
| -32% | -$527K | ﹤0.01% | 2582 |
|
|
2017
Q2 | $1.52M | Sell |
132,524
-111,283
| -46% | -$1.27M | ﹤0.01% | 2071 |
|
|
2017
Q1 | $5.07M | Buy |
243,807
+40,260
| +20% | +$837K | ﹤0.01% | 1410 |
|
|
2016
Q4 | $4.23M | Buy |
203,547
+708
| +0.3% | +$14.7K | ﹤0.01% | 1531 |
|
|
2016
Q3 | $6.65M | Buy |
202,839
+15,927
| +9% | +$522K | 0.01% | 1258 |
|
|
2016
Q2 | $4.67M | Buy |
186,912
+279
| +0.1% | +$6.97K | 0.01% | 1489 |
|
|
2016
Q1 | $4.57M | Buy |
186,633
+72,636
| +64% | +$1.78M | 0.01% | 1437 |
|
|
2015
Q4 | $3.77M | Buy |
113,997
+20,332
| +22% | +$672K | ﹤0.01% | 1662 |
|
|
2015
Q3 | $3.07M | Buy |
93,665
+36,411
| +64% | +$1.19M | ﹤0.01% | 1812 |
|
|
2015
Q2 | $3.03M | Buy |
57,254
+20,794
| +57% | +$1.1M | ﹤0.01% | 2004 |
|
|
2015
Q1 | $1.05M | Buy |
36,460
+21,396
| +142% | +$617K | ﹤0.01% | 2682 |
|
|
2014
Q4 | $439K | Sell |
15,064
-2,300
| -13% | -$67K | ﹤0.01% | 3441 |
|
|
2014
Q3 | $220K | Buy |
+17,364
| New | +$220K | ﹤0.01% | 3695 |
|